Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients: a multicenter, open-label, phase III study.

Zeng MS, Ye HY, Guo L, Peng WJ, Lu JP, Teng GJ, Huan Y, Li P, Xu JR, Liang CH, Breuer J.

Hepatobiliary Pancreat Dis Int. 2013 Dec;12(6):607-16.

PMID:
24322746
2.

Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.

Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J.

Invest Radiol. 2010 Mar;45(3):133-41. doi: 10.1097/RLI.0b013e3181caea5b.

PMID:
20098330
3.

Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation.

Böttcher J, Hansch A, Pfeil A, Schmidt P, Malich A, Schneeweiss A, Maurer MH, Streitparth F, Teichgräber UK, Renz DM.

Eur J Radiol. 2013 Nov;82(11):1860-9. doi: 10.1016/j.ejrad.2013.06.013. Epub 2013 Aug 7.

PMID:
23932636
4.

Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.

Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, Casalino DD, Davis PL, Francis IR, Krinsky G, Lee FT Jr, Lu D, Paulson EK, Schwartz LH, Siegelman ES, Small WC, Weber TM, Welber A, Shamsi K.

Radiology. 2005 Oct;237(1):89-98. Epub 2005 Aug 26.

PMID:
16126918
5.

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.

Hammerstingl R, Huppertz A, Breuer J, Balzer T, Blakeborough A, Carter R, Fusté LC, Heinz-Peer G, Judmaier W, Laniado M, Manfredi RM, Mathieu DG, Müller D, Mortelè K, Reimer P, Reiser MF, Robinson PJ, Shamsi K, Strotzer M, Taupitz M, Tombach B, Valeri G, van Beers BE, Vogl TJ; European EOB-study group.

Eur Radiol. 2008 Mar;18(3):457-67. Epub 2007 Dec 6.

PMID:
18058107
6.

Detection of liver metastasis: is diffusion-weighted imaging needed in Gd-EOB-DTPA-enhanced MR imaging for evaluation of colorectal liver metastases?

Tajima T, Akahane M, Takao H, Akai H, Kiryu S, Imamura H, Watanabe Y, Kokudo N, Ohtomo K.

Jpn J Radiol. 2012 Oct;30(8):648-58. doi: 10.1007/s11604-012-0105-4. Epub 2012 Jul 18.

PMID:
22836904
7.

Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions.

Haimerl M, Wächtler M, Platzek I, Müller-Wille R, Niessen C, Hoffstetter P, Schreyer AG, Stroszczynski C, Wiggermann P.

BMC Med Imaging. 2013 Dec 1;13:41. doi: 10.1186/1471-2342-13-41.

8.

Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.

Donati OF, Fischer MA, Chuck N, Hunziker R, Weishaupt D, Reiner CS.

Eur J Radiol. 2013 May;82(5):822-8. doi: 10.1016/j.ejrad.2012.12.005. Epub 2012 Dec 31.

PMID:
23287713
9.

Dynamic MR imaging of liver metastases with Gd-EOB-DTPA.

Stern W, Schick F, Kopp AF, Reimer P, Shamsi K, Claussen CD, Laniado M.

Acta Radiol. 2000 May;41(3):255-62.

PMID:
10866081
10.

Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.

Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, Merkle EM.

Eur J Radiol. 2012 Oct;81(10):2457-62. doi: 10.1016/j.ejrad.2011.10.014. Epub 2011 Dec 3.

PMID:
22138122
11.

Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.

Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, Schwarz W, Müller PK, Bechstein WO, Mack MG, Söllner O, Felix R.

Radiology. 1996 Jul;200(1):59-67.

PMID:
8657946
12.

Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).

Motosugi U, Ichikawa T, Sou H, Sano K, Ichikawa S, Tominaga L, Araki T.

J Magn Reson Imaging. 2009 Oct;30(4):849-54. doi: 10.1002/jmri.21913.

PMID:
19787734
13.

Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.

Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, Hesse T, Berns T, Peters PE.

Radiology. 1996 Apr;199(1):177-83.

PMID:
8633143
14.

Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.

Yonetomi D, Kadosawa T, Miyoshi K, Nakao Y, Homma E, Hanazono K, Yamada E, Nakamura K, Ijiri A, Minegishi N, Maetani S, Hirayama K, Taniyama H, Nakade T.

Vet Radiol Ultrasound. 2012 Jul-Aug;53(4):371-80. doi: 10.1111/j.1740-8261.2011.01919.x. Epub 2012 May 1.

PMID:
22548505
15.

[Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].

Portilha MA, Pedro MT, Ruivo C, Semedo LC, Marques C, Alves FC.

Acta Med Port. 2011 Dec;24 Suppl 2:531-8. Epub 2011 Dec 31. Portuguese.

16.

Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging.

Reimer P, Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tombach B, Peters PE.

Eur Radiol. 1997;7(2):275-80.

PMID:
9038130
17.

[Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].

Zhang HM, Ouyang H, Zhou CW.

Zhonghua Zhong Liu Za Zhi. 2006 Feb;28(2):111-5. Chinese.

PMID:
16750014
18.

Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.

Gschwend S, Ebert W, Schultze-Mosgau M, Breuer J.

Invest Radiol. 2011 Sep;46(9):556-66. doi: 10.1097/RLI.0b013e31821a218a.

PMID:
21623212
19.

Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.

Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S, Murakami T.

J Gastroenterol. 2012 Sep;47(9):1036-47. doi: 10.1007/s00535-012-0571-6. Epub 2012 Apr 17.

PMID:
22526270
20.

Early phase detection of bile leak after hepatobiliary surgery: value of Gd-EOB-DTPA-enhanced MR cholangiography.

Alegre Castellanos A, Molina Granados JF, Escribano Fernandez J, Gallardo Muñoz I, Triviño Tarradas Fde A.

Abdom Imaging. 2012 Oct;37(5):795-802.

PMID:
22213118

Supplemental Content

Support Center